Duxbury, MA, United States of America

Elizabeth Trehu

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Cancer Treatment by Elizabeth Trehu

Introduction

Elizabeth Trehu is an accomplished inventor based in Duxbury, MA (US). She has made significant contributions to the field of cancer treatment, particularly in the area of fibrotic cancers. Her innovative approaches have the potential to improve therapeutic outcomes for patients suffering from these challenging conditions.

Latest Patents

Elizabeth Trehu holds a patent for "Methods for treating fibrotic cancers." This patent outlines methods of treating fibrotic cancers by administering one or more Serum Amyloid Protein (SAP) agonists. In certain aspects, the method further comprises the conjoint administration of an anti-cancer therapeutic, such as a chemotherapeutic agent. Additionally, the disclosure relates to methods of treating myelofibrosis by administering an SAP agonist and optionally one or more anti-cancer therapeutic agents. This patent highlights her commitment to advancing cancer treatment methodologies.

Career Highlights

Elizabeth Trehu is currently associated with Promedior, Inc., where she continues to work on innovative solutions for cancer treatment. Her expertise and dedication to research have positioned her as a key figure in her field. With a focus on developing effective therapies, she has made strides in understanding and addressing the complexities of fibrotic cancers.

Collaborations

Elizabeth collaborates with notable professionals in her field, including Suzanne Bruhn and Mark L Lupher, Jr. These partnerships enhance her research efforts and contribute to the development of groundbreaking treatments.

Conclusion

Elizabeth Trehu's work in the realm of cancer treatment exemplifies the impact of innovation in medicine. Her patent for treating fibrotic cancers showcases her dedication to improving patient outcomes. Through her career and collaborations, she continues to pave the way for advancements in cancer therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…